The role of tumour FoxP3 as prognostic marker in different subtypes of head and neck cancer

European Journal of Cancer

Volumn 50, Issue 7, 2014, Pages 1291-1300

  Weller, Patrick ^a   Bankfalvi, Agnes ^a   Gu, Xiang ^a   Dominas, Nina ^a   Lehnerdt, Götz F ^a   Zeidler, Reinhard ^b,c   Lang, Stephan ^a   Brandau, Sven ^a   Dumitru, Claudia A ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

AHNAK; Biomarker combinations; CORTACTIN; COX2; Head and neck cancer; Overall survival; Prognosis; Tumour FoxP3

Indexed keywords

CORTACTIN; CYCLOOXYGENASE 2; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; CANCER PROGNOSIS; CONTROLLED STUDY; CYTOSKELETON; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OROHYPOPHARYNX SQUAMOUS CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; TUMOR CELL;

AHNAK; BIOMARKER COMBINATIONS; CORTACTIN; COX2; HEAD AND NECK CANCER; OVERALL SURVIVAL; PROGNOSIS; TUMOUR FOXP3;

ADULT; CARCINOMA, SQUAMOUS CELL; CORTACTIN; CYCLOOXYGENASE 2; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MEMBRANE PROTEINS; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84897389313     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.02.016     Document Type: Article

References (27)

1. S.I. Pai, and W.H. Westra Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment Annu Rev Pathol 4 2009 49 70
2. Ries Lagy JL, Eisner MP, Lin YD, Horner MJ, editors. Cancer survival among adults: U.S. SEER program, 1988-2001. Patient and tumor characteristics. National Cancer Institute, SEER Program; 2007.
3. G. Almadori, F. Bussu, G. Cadoni, J. Galli, G. Paludetti, and M. Maurizi Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach Eur J Cancer 41 2005 683 693
4. A. Jemal, R.C. Tiwari, and T. Murray et al. Cancer statistics, 2004 CA Cancer J Clin 54 2004 8 29
5. Q. Huang, G.P. Yu, and S.A. McCormick et al. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression Genes Chromosomes Cancer 34 2002 224 233
6. N. Choong, and E. Vokes Expanding role of the medical oncologist in the management of head and neck cancer CA Cancer J Clin 58 2008 32 53
7. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M.J. Thun Cancer statistics, 2007 CA Cancer J Clin 57 2007 43 66
8. A.L. Carvalho, I.N. Nishimoto, J.A. Califano, and L.P. Kowalski Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database Int J Cancer 114 2005 806 816
9. Y. Wu, M. Borde, and V. HeissMeier et al. FOXP3 controls regulatory T cell function through cooperation with NFAT Cell 126 2006 375 387
10. G.Y. Chen, C. Chen, L. Wang, X. Chang, P. Zheng, and Y. Liu Cutting edge: broad expression of the FoxP3 locus in epithelial cells: a caution against early interpretation of fatal inflammatory diseases following in vivo depletion of FoxP3-expressing cells J Immunol 180 2008 5163 5166
11. V. Karanikas, M. Speletas, and M. Zamanakou et al. Foxp3 expression in human cancer cells J Transl Med 6 2008 19
12. T. Triulzi, E. Tagliabue, A. Balsari, and P. Casalini FOXP3 expression in tumor cells and implications for cancer progression J Cell Physiol 228 2013 30 35
13. S. Ladoire, L. Arnould, and G. Mignot et al. Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy Breast Cancer Res Treat 125 2011 65 72
14. F.I. Dimitrakopoulos, H. Papadaki, and A.G. Antonacopoulou et al. Association of FOXP3 expression with non-small cell lung cancer Anticancer Res 31 2011 1677 1683
15. P. Quaglino, S. Osella-Abate, and F. Marenco et al. FoxP3 expression on melanoma cells is related to early visceral spreading in melanoma patients treated by electrochemotherapy Pigment Cell Melanoma Res 24 2011 734 736
16. L.H. Wang, L. Su, and J.T. Wang Correlation between elevated FOXP3 expression and increased lymph node metastasis of gastric cancer Chin Med J (Engl) 123 2010 3545 3549
17. L. Xue, H.Q. Lu, and J. He et al. Expression of FOXP3 in esophageal squamous cell carcinoma relating to the clinical data Dis Esophagus 23 2010 340 346
18. M.E. Winerdal, P. Marits, and M. Winerdal et al. FOXP3 and survival in urinary bladder cancer BJU Int 108 2011 1672 1678
19. Y.J. Liang, H.C. Liu, and Y.X. Su et al. Foxp3 expressed by tongue squamous cell carcinoma cells correlates with clinicopathologic features and overall survival in tongue squamous cell carcinoma patients Oral Oncol 47 2011 566 570
20. S. Itoh, K. Matsui, I. Furuta, and Y. Takano Immunohistochemical study on overexpression of cyclooxygenase-2 in squamous cell carcinoma of the oral cavity: its importance as a prognostic predictor Oral Oncol 39 2003 829 835
21. M.K. Sackett, I. Bairati, and F. Meier et al. Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer Clin Cancer Res 14 2008 67 73
22. C.A. Dumitru, A. Bankfalvi, X. Gu, R. Zeidler, S. Brandau, and S. Lang AHNAK and inflammatory markers predict poor survival in laryngeal carcinoma PLoS One 8 2013 e56420
23. C.A. Dumitru, A. Bankfalvi, and X. Gu et al. Neutrophils activate tumoral CORTACTIN to enhance progression of orohypopharynx carcinoma Front Immunol 4 2013 33
24. P. Hofman, C. Butori, and K. Havet et al. Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status Br J Cancer 98 2008 956 964
25. K.Y. Kim, S. Li, J.D. Cha, X. Zhang, and I.H. Cha Significance of molecular markers in survival prediction of oral squamous cell carcinoma Head Neck 34 2012 929 936
26. A.G. Ammer, and S.A. Weed Cortactin branches out: roles in regulating protrusive actin dynamics Cell Motil Cytoskeleton 65 2008 687 707
27. J. Shankar, A. Messenberg, J. Chan, T.M. Underhill, L.J. Foster, and I.R. Nabi Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells Cancer Res 70 2010 3780 3790